ClinicalTrials.gg
CompletedNCT03437824Updated Apr 9, 2019

Effects of Vitamin B12 Treatment in Singers

An Early Phase 1 interventional study of Cyanocobalamin and Placebo in Vitamin B 12 Deficiency, sponsored by University of Southern California. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-04-09.

Sponsored by University of Southern California · Early Phase 1, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Apr 2019, 7 years 7 months ago, and no results have been posted to the registry.
Phase
Early Phase 1
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

In this study, the investigators aim to assess if vitamin B12 treatment demonstrates a beneficial effect on voice performance. If so, they wish to examine the relationship between the vitamin B12 treatment and the study participant's general well-being.

Read the detailed description

Through the investigators' experience, they have observed that amongst singers and voice professionals, there is a common belief that there are voice benefits from cobalamin treatment. Consequently, some singers and voice professionals tend to ask for cobalamin injections in order to enhance their vocal performance. However, there are no previous reports that illustrate the effects of vitamin B12 deficiency or treatment on voice performance.

02

Conditions studied

  • Vitamin B 12 Deficiency
03

In context

Vitamin B 12 Deficiency

73 studies on the registry are indexed under Vitamin B 12 Deficiency; 8 are open to participants now.

This study's enrollment of 20 is below the median of 70 across 45 interventional studies indexed under Vitamin B 12 Deficiency.

Browse Vitamin B 12 Deficiency studies →

Lead sponsor

University of Southern California is the lead sponsor of 791 studies on the registry; 136 are open to participants now.

Of its 70 completed or terminated interventional studies of FDA-regulated products, 32 (46%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 to 65 years old
  • An active singer who is presently singing
  • Willing and able to comply with the study requirements
  • Completed and signed an form.

Exclusion criteria

Exclusion Criteria:

  • Known vitamin B12 deficiency
  • Active or recent vitamin B12 treatment (the subject must not receive vitamin B12 treatment for at least 4 weeks)
  • Any known bleeding disorder
  • Any known laryngeal pathology
  • Plans to start any new treatment, oral/parenteral anticoagulant, supplement, or medication during the study period
  • Scored above the highest 10 percentile of performance in all three voice evaluation questionnaires will be withdrawn from the study before the first injection (i.e., scored less than or equal to 7 in the Voice Fatigue Index (VFI), less than or equal to 6 in the Evaluation of the Ability to Sing Easily (EASE), and less than or equal to 4 in the Singing Voice Handicap Index 10 (SVHI-10))
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Cyanocobalamin

    Vitamin B12, 1,000 mg, Once

    Drug: Cyanocobalamin

  • Placebo comparator
    Placebo

    Normal Saline Solution (0.9% Sodium Chloride), Once

    Drug: Placebo

Interventions

  • 1,000 mg, Once

    Also known as: Vitamin B12

  • DrugPlacebo

    0.9% Sodium Chloride, Once

    Also known as: Normal Saline Solution

06

What researchers measure

Primary outcomes

  1. Evaluation of the Ability to Sing Easily (EASE) - Change

    1 = Not at All, 2 = Mildly, 3 = Moderately, 4 = Extremely

    Time frame: Baseline, 1 Hr Post-Injection, 3 Hrs Post-Injection, 24 Hrs Post-Injection, 72 Hrs Post-Injection, 1 Wk Post-Injection

  2. Singing Voice Handicap Index-10 (SVHI-10) - Change

    0 = Never, 1 = Almost Never, 2 = Sometimes, 3 = Almost Always, 4 = Always

    Time frame: Baseline, 1 Hr Post-Injection, 3 Hrs Post-Injection, 24 Hrs Post-Injection, 72 Hrs Post-Injection, 1 Wk Post-Injection

  3. 0-10 Visual Analog Scale (VAS) - Change

    The scale asks, "How confident are you that your voice will do what you need it to do right now?"; 0 = Not Confident At All, 10 = Extremely Confident

    Time frame: Baseline, 1 Hr Post-Injection, 3 Hrs Post-Injection, 24 Hrs Post-Injection, 72 Hrs Post-Injection, 1 Wk Post-Injection

  4. Vocal Fold Swelling (Bastian et al., 2009) - Change

    Happy Birthday, Staccato, Trill; 1 = Poor, 5 = Average, 10 = Excellent

    Time frame: Baseline, 1 Hr Post-Injection, 3 Hrs Post-Injection, 24 Hrs Post-Injection, 72 Hrs Post-Injection, 1 Wk Post-Injection

  5. Voice Fatigue Index (VFI) - Change

    0 = Never, 1 = Almost Never, 2 = Sometimes, 3 = Almost Always, 4 = Always

    Time frame: Baseline, 1 Hr Post-Injection, 3 Hrs Post-Injection, 24 Hrs Post-Injection, 72 Hrs Post-Injection, 1 Wk Post-Injection

Secondary outcomes

  1. Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS) - Change

    1 = Not at All, 5 = Extremely

    Time frame: Baseline, 1 Hr Post-Injection, 3 Hrs Post-Injection, 24 Hrs Post-Injection, 72 Hrs Post-Injection, 1 Wk Post-Injection

  2. Patients Health Questionnaire-9 for Depression - Change

    0 = Not at All, 3 = Extremely

    Time frame: Baseline, 1 Hr Post-Injection, 3 Hrs Post-Injection, 24 Hrs Post-Injection, 72 Hrs Post-Injection, 1 Wk Post-Injection

07

Study locations

1 site
  • Keck Medicine of USC - Downtown Los Angeles
    Los Angeles, California 90017, United States
08

References and documents

Publications

  • Shoffel-Havakuk H, Lava CX, Reuven Y, Moog D, Odell K, Reder LS, Hapner ER, Johns MM 3rd. Effect of Vitamin B12 Injection on the Vocal Performance of Professional Singers: A Randomized, Double-blind, Placebo-Controlled, Crossover Trial. JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):9-15. doi: 10.1001/jamaoto.2020.4026. PubMed 33180098 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03437824
Responsible party
Michael Johns (Principal Investigator, University of Southern California) — Principal investigator
First posted
Feb 19, 2018
Start date
Oct 1, 2017
Primary completion
Apr 1, 2019
Completion
Apr 1, 2019
Last update
Apr 9, 2019

Study contacts

Hagit Shoffel-Havakuk, MD
study director · University of Southern California

Oversight

FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Vitamin B 12

Start the discussion